SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

JB Chemicals & Pharmaceuticals board to consider unaudited financial results

13 Oct 2015 Evaluate

JB Chemicals & Pharmaceuticals has informed that the meeting of the Board of Directors of the company will be held on November 04, 2015 to consider and approve unaudited financial results for the quarter ended on September 30, 2015. Further, as per company’s code of conduct framed pursuant to the SEBI (Prohibition of Insider Trading) Regulations, the trading window for dealing in the securities of Company stands closed from October 01, 2015 until further notice in connection with declaration of unaudited financial results for the quarter ended on September 30, 2015.

The above information is a part of company’s filings submitted to BSE.

JB Chem & Pharma Share Price

1999.50 -12.45 (-0.62%)
24-Apr-2026 09:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.00
Dr. Reddys Lab 1310.85
Cipla 1268.40
Zydus Lifesciences 940.65
Lupin 2336.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×